Szeged, Hungary

István Kanizsai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Avidin Co. Ltd., Soneas Research Co. Ltd., Synaging Sas. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: István Kanizsai. Retrieved from https://idiyas.com/inventor/istván-kanizsai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of István Kanizsai

Introduction

István Kanizsai is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on enantiomers of 8-hydroxyquinoline derivatives. His research focuses on the synthesis and application of these compounds in pharmaceutical compositions.

Latest Patents

Kanizsai holds a patent for "Enantiomers of 8-hydroxyquinoline derivatives and the synthesis thereof." This invention introduces novel enantiomer derivatives of 8-hydroxyquinoline, which have not been previously disclosed in prior art. The patent emphasizes the biological effects and characteristics of these enantiomers, which are crucial for developing effective medicinal and pharmaceutical compositions. The compounds are particularly useful as cytoprotective, neuroprotective, cardioprotective, anxiolytic, and antidepressant agents for treating various neuropsychiatric and neurologic diseases.

Career Highlights

Throughout his career, Kanizsai has worked with several companies, including Avidin Co. Ltd. and Soneas Research Co. Ltd. His experience in these organizations has contributed to his expertise in the field of medicinal chemistry and patent development.

Collaborations

Kanizsai has collaborated with notable professionals in his field, including László Puskás and Thierry Pillot. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

István Kanizsai's innovative work on enantiomers of 8-hydroxyquinoline derivatives showcases his significant contributions to medicinal chemistry. His patent and collaborations reflect his commitment to advancing pharmaceutical science and improving treatment options for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…